Jan Kimpen is the Philips Chief Medical Officer, a position he has held since January 2016.
As the functional leader for clinical innovation, medical affairs and health economics, Jan and his team work collaboratively to advance clinical capabilities at Philips and to support organic and external growth opportunities.
Jan also leads the Medical Leadership Team, with responsibility for the company’s medical strategy. This includes advocacy, customer partnerships and responsibility for clinical trials and medical guidelines. He also leads health economics and market access for Philips, and is closely involved in M&A.
A frequent speaker on eHealth and digital innovation, Jan also represents Philips on the Global Health Security Agenda private sector roundtable and the WEF Global Health Security Advisory Board.
Jan joined the company from the University Medical Center Utrecht - one of the largest healthcare organizations in the Netherlands - where he served as professor and chairman of Pediatrics before being appointed as CEO in 2009.